The Original Investigation titled “Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: the PDA Randomized Clinical Trial,” published on February 17, 2026, was corrected to remove and add names to the byline. “Anne Marie Reynolds, MD, MPH” was removed from the byline and “Praveen K. Chandrasekharan, MD, MS” was added where Dr Reynolds’ name had appeared. Dr Reynolds’ information was added to the “Additional Contributions” section. This article was corrected online.
Reference
- 1.Laughon MM, Thomas SM, Watterberg KL, et al. ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network . Expectant management vs medication for patent ductus arteriosus in preterm infants: the PDA randomized clinical trial. JAMA. 2026;335(7):588-599. doi: 10.1001/jama.2025.23330 [DOI] [PMC free article] [PubMed] [Google Scholar]
